Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald A Smith

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Annals of Internal Medicine|November 20, 2018
Review: Long-chain ω-3 fatty acids have no effect on mortality or overall cardiovascular eventsDonald A Smith
Evidence-Based Medicine|February 1, 2008
Subclavian stenosis was associated with an increase in all-cause and cardiovascular mortality at a mean of 9.4 yearsDonald A Smith
Annals of Internal Medicine|May 21, 2014
ACP Journal Club. Review: statins are not associated with cognitive impairment or dementia in cognitively intact adultsDonald A Smith
Annals of Internal Medicine|April 18, 2012
ACP Journal Club. Adding niacin to simvastatin did not improve clinical outcomes in patients with CV disease and dyslipidemiaDonald A Smith
Endocrinology and Metabolism Clinics of North America|November 30, 2014
LipidsDonald A Smith
Annals of Internal Medicine|March 15, 2016
In adults without CVD, the MESA score, including coronary artery calcium, predicted 10-y risk for CHD eventsDonald A Smith
The Medical Clinics of North America|October 30, 2007
Treatment of the dyslipidemia of insulin resistanceDonald A Smith
Annals of Internal Medicine|December 19, 2012
ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adultsDonald A Smith
Annals of Internal Medicine|October 16, 2013
ACP Journal Club. A lifestyle intervention did not reduce cardiovascular outcomes in overweight or obese patients with type 2 diabetesDonald A Smith
Cardiology|April 25, 2008
Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patientDonald A Smith
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Annals of Internal Medicine|November 20, 2018
Review: Long-chain ω-3 fatty acids have no effect on mortality or overall cardiovascular eventsDonald A Smith
Evidence-Based Medicine|February 1, 2008
Subclavian stenosis was associated with an increase in all-cause and cardiovascular mortality at a mean of 9.4 yearsDonald A Smith
Annals of Internal Medicine|May 21, 2014
ACP Journal Club. Review: statins are not associated with cognitive impairment or dementia in cognitively intact adultsDonald A Smith
Annals of Internal Medicine|April 18, 2012
ACP Journal Club. Adding niacin to simvastatin did not improve clinical outcomes in patients with CV disease and dyslipidemiaDonald A Smith
Endocrinology and Metabolism Clinics of North America|November 30, 2014
LipidsDonald A Smith
Annals of Internal Medicine|March 15, 2016
In adults without CVD, the MESA score, including coronary artery calcium, predicted 10-y risk for CHD eventsDonald A Smith
The Medical Clinics of North America|October 30, 2007
Treatment of the dyslipidemia of insulin resistanceDonald A Smith
Annals of Internal Medicine|December 19, 2012
ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adultsDonald A Smith
Annals of Internal Medicine|October 16, 2013
ACP Journal Club. A lifestyle intervention did not reduce cardiovascular outcomes in overweight or obese patients with type 2 diabetesDonald A Smith
Cardiology|April 25, 2008
Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patientDonald A Smith
Pageof 6